## **Core Concept**
Multibacillary leprosy is a more severe form of leprosy characterized by a higher bacterial load and more widespread disease. It requires more intensive treatment and follow-up to monitor for complications and detect any signs of relapse early. The follow-up strategy is crucial for managing the disease effectively.

## **Why the Correct Answer is Right**
The correct answer, **5 years**, is based on the World Health Organization (WHO) recommendations for the follow-up of patients with multibacillary leprosy. After completion of multidrug therapy (MDT), patients are followed up for a certain period to detect any signs of relapse early. The recommended follow-up period for multibacillary leprosy is yearly for 5 years. This duration is chosen because most relapses occur within the first 5 years after treatment.

## **Why Each Wrong Option is Incorrect**
- **Option A: 2 years** - This duration is too short for adequate follow-up of multibacillary leprosy patients, as it does not cover the full period during which relapses are most likely to occur.
- **Option B: 3 years** - Similarly, 3 years is also insufficient for ensuring that the patient does not have a relapse, given the higher risk in multibacillary leprosy.
- **Option C: 10 years** - While extended follow-up can be beneficial, the WHO and other guidelines specifically recommend 5 years of follow-up for multibacillary leprosy, making 10 years more than what is generally advised.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that after completing treatment for multibacillary leprosy, patients should be followed up **yearly for 5 years** to monitor for signs of relapse. Early detection of relapse is crucial for preventing long-term disability.

## **Correct Answer:** D. 5 years